Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Source filing unavailable
Q4 2014 · —
Revenue$5.36B$5.36B+5.6% vs Q4 2013 Net Income$905.00M$905.00M+53.7% vs Q4 2013 EPS Diluted$0.59$0.59+59.5% vs Q4 2013 Gross Profit$2,856,000,000+12.0% Operating Incomederived$829,000,000+98.3% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,238,000,000−23.8% Free Cash Flowderived$951,000,000−28.1% Margins · derivedGross margin53.3%+3.0 pt vs Q4 2013
Operating margin15.5%+7.2 pt vs Q4 2013
Net margin16.9%+5.3 pt vs Q4 2013